A research team led by the University of California, Riverside, has discovered important details about how therapeutically relevant human monoclonal antibodies can protect against Crimean Congo Hemorrhagic Fever virus, or ...
Nov 28, 2022
0
25
A significant concern after a person receives an organ transplant from a donor is antibody mediated rejection (AMR)—a process by which antibodies in the recipient can cause their immune systems to reject and damage the ...
Nov 23, 2022
0
23
Three currently circulating omicron subvariants of SARS-CoV-2—including two that currently make up almost 50% of reported COVID-19 infections in the U.S.—are better at evading vaccine- and infection-generated neutralizing ...
Nov 22, 2022
1
95
Muscle stem cells, the cells in muscle fibers that generate new muscle cells after injury or exercise, lose their potency with age. But a study by researchers at Stanford Medicine shows that old mice regain the leg muscle ...
Nov 17, 2022
0
48
The method by which a baby was delivered is associated with how its immune system will respond to two key childhood vaccines, research suggests.
Nov 15, 2022
0
54
Pregnant people who received one of the mRNA COVID-19 vaccines had 10-fold higher antibody concentrations than those who were naturally infected with SARS-CoV-2, a finding that was also observed in their babies, according ...
Nov 9, 2022
0
80
The type of virus used as a model to study the efficacy of non-neutralizing antibodies against the virus responsible for AIDS has a crucial role to play, according to a new study led by Andrés Finzi, Université de Montréal ...
Nov 8, 2022
0
81
An international team of researchers has used mRNA technology to develop an influenza vaccine that targets four proteins that tend to change little across viral strains. In their paper published in Proceedings of the National ...
One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found. The antibody ...
Oct 31, 2022
0
78
A new study from scientists at La Jolla Institute for Immunology (LJI) gives researchers a guide to neutralizing Lassa virus using a trio of rare antibodies isolated from survivors of Lassa virus infection.
Oct 26, 2022
0
41
